Effects of atorvastatin combined with low-molecular-weight heparin on plasma inflammatory cytokine level and pulmonary 
pathophysiology of rats with sepsis

Jing,Fei; Li,Ming; Ren,Hongsheng; Zhang,Jitian; Yao,Qingchun; Chu,Yufeng; Wang,Chunting

doi:10.3892/etm.2016.3372

Effects of atorvastatin combined with low-molecular-weight heparin on plasma inflammatory cytokine level and pulmonary pathophysiology of rats with sepsis

Authors:
- Fei Jing
- Ming Li
- Hongsheng Ren
- Jitian Zhang
- Qingchun Yao
- Yufeng Chu
- Chunting Wang
View Affiliations

Affiliations: Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China, Department of Rheumatology and Clinical Immunology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China, Department of Intensive Care Unit, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China, Department of Nutrition, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China
Published online on: May 20, 2016 https://doi.org/10.3892/etm.2016.3372
Pages: 1048-1054
Copyright: © Jing et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effect of atorvastatin combined with low-molecular-weight heparin (LMWH) on plasma early inflammatory cytokine levels as well as pulmonary pathophysiology of rats with sepsis. A total of 122 rats were randomly divided into five groups including the sham operation group (n=10), CLP group (n=10), atorvastatin group (n=34, 20 mg/kg/day), LMWH group (n=34, 100 IU/kg/day), and atorvastatin combined with LMWH group (n=34). Blood samples from 6 rats in each group were collected to detect TNF-α, IL-1β and HMGB1 concentration in plasma by linked immunosorbent assay at baseline and postoperatively at 4, 8, 12 and 24 h. Pulmonary pathophysiology was observed postoperatively at 24 h. The remaining 10 rats in each group were used to calculate the 7-day cumulative mortality rate. Compared to the sham operation group, the scores in CLP were greater than those of the sham operation group (P<0.05). Compared to the CLP group, the sepsis severity scores of the atorvastatin, LMWH, and atorvastatin combined with LMWH groups decreased gradually. Significant difference was detected in the four groups (P<0.05 0.01). Compared to the sham operation group, at 4, 8, 12 and 24 h, the TNF-α, IL-1β and HMGB1 levels in plasma in CLP increased significantly (P<0.01). Compared to the CLP group, the TNF-α, IL-1β and HMGB1 levels of plasma in other groups decreased gradually, and there was a significant difference in the four groups (P<0.01). At 24 h post operation, compared to the sham operation group, the damage of pulmonary pathophysiology in CLP was more severe. Compared to the CLP group, the damage of pulmonary pathophysiology in other groups was slight. Compared to the CLP group, the 7-day cumulative mortality rate in other groups decreased significantly (P<0.05). In conclusion, atorvastatin, combined with LMWH can decrease sepsis severity, plasma inflammatory cytokine levels, pulmonary pathophysiology, and the 7-day cumulative mortality rate. Atorvastatin, and LMWH may therefore be useful for the treatment of sepsis due to its ability to inhibit the release of TNF-α, IL-1β and HMGB1 in septic rats.

View Figures

View References

1	Sakr Y, Elia C, Mascia L, Barberis B, Cardellino S, Livigni S, Fiore G, Filippini C and Ranieri VM: Epidemiology and outcome of sepsis syndromes in Italian ICUs: a muticentre, observational cohort study in the region of Piedmont. Minerva Anestesiol. 79:993–1002. 2013.PubMed/NCBI
2	Kobashi H, Toshimori J and Yamamoto K: Sepsis-associated liver injury: incidence, classification and the clinical significance. Hepatol Res. 43:255–266. 2013. View Article : Google Scholar : PubMed/NCBI
3	Diament D, Salomão R, Rigatto O, Gomes B, Silva E, Carvalho NB and Machado FR: Guidelines for the treatment of severe sepsis and septic shock - management of the infectious agent - diagnosis. Rev Bras Ter Intensiva. 23:134–144. 2011.(In Portuguese). PubMed/NCBI
4	Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al: Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup: Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 39:165–228. 2013. View Article : Google Scholar : PubMed/NCBI
5	Fukushima H, Nishio K, Asai H, Watanabe T, Seki T, Matsui H, Sugimoto M, Matsumoto M, Fujimura Y and Okuchi K: Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis. Shock. 39:409–414. 2013. View Article : Google Scholar : PubMed/NCBI
6	Hatherill M, Tibby SM, Turner C, Ratnavel N and Murdoch IA: Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med. 28:2591–2594. 2000. View Article : Google Scholar : PubMed/NCBI
7	King EG, Bauzá GJ, Mella JR and Remick DG: Pathophysiologic mechanisms in septic shock. Lab Invest. 94:4–12. 2014. View Article : Google Scholar : PubMed/NCBI
8	Aslani F, Schuppe HC, Guazzone VA, Bhushan S, Wahle E, Lochnit G, Lustig L, Meinhardt A and Fijak M: Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis. Hum Reprod. 30:417–431. 2015. View Article : Google Scholar : PubMed/NCBI
9	Subramani J, Kathirvel K, Leo MD, Kuntamallappanavar G, Uttam Singh T and Mishra SK: Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis. J Cardiovasc Pharmacol. 54:526–534. 2009. View Article : Google Scholar : PubMed/NCBI
10	Lu X, Zhao L and Xu YH: Low molecular weight heparin prevents CLP-induced acute lung injury in rats by anti-inflammatory coagulation. Bosn J Basic Med Sci. 13:50–56. 2013.PubMed/NCBI
11	Liu FY and Liu TF: Experimental zoology. Beijing China Science and Technology Press. Beijing: 209–210. 2005.(In Chinese).
12	Wichterman KA, Baue AE and Chaudry IH: Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res. 29:189–201. 1980. View Article : Google Scholar : PubMed/NCBI
13	Levi M, van der Poll T and Schultz M: New insights into pathways that determine the link between infection and thrombosis. Neth J Med. 70:114–120. 2012.PubMed/NCBI
14	Schouten M, Wiersinga WJ, Levi M and van der Poll T: Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol. 83:536–545. 2008. View Article : Google Scholar : PubMed/NCBI
15	Zhang L and An YZ: The stage-biomarkers of the sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 23:509–512. 2011.(In Chinese). PubMed/NCBI
16	Khalid U, Jenkins RH, Pino-Chavez G, Bowen T, Fraser DJ and Chavez R: A localized ischemic preconditioning regimen increases tumor necrosis factor α expression in a rat model of kidney ischemia-reperfusion injury. Exp Clin Transplant. 13:535–542. 2015.PubMed/NCBI
17	Zou JL, Yin ZP, Zhang LQ, Wang YQ and Qi GX: Expression of TNG-α and IL-6 in tissues and serums in the early stage of myocardial ischemia-reperfusion in rat. J China Med Univ. 25:541–543. 2013.(In Chinese).
18	Zhao L, An R, Yang Y, Yang X, Liu H, Yue L, Li X, Lin Y, Reiter RJ and Qu Y: Melatonin alleviates brain injury in mice subjected to cecal ligation and puncture via attenuating inflammation, apoptosis, and oxidative stress: the role of SIRT1 signaling. J Pineal Res. 59:230–239. 2015. View Article : Google Scholar : PubMed/NCBI
19	Bosmann M, Russkamp NF and Ward PA: Fingerprinting of the TLR4-induced acute inflammatory response. Exp Mol Pathol. 93:319–323. 2012. View Article : Google Scholar : PubMed/NCBI
20	Zhu H, Cai PP, Yin X and Zhu J: Role of high mobility group protein B1 in acute lung injury in rats with sepsis. Chin J Crit Care Med. 23:253–254. 2011.(In Chinese).
21	Ito T, Kawahara K, Nakamura T, Yamada S, Nakamura T, Abeyama K, Hashiguchi T and Maruyama I: High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost. 5:109–116. 2007. View Article : Google Scholar : PubMed/NCBI
22	Wang H and Liu D: Baicalin inhibits high-mobility group box 1 release and improves survival in experimental sepsis. Shock. 41:324–330. 2014. View Article : Google Scholar : PubMed/NCBI
23	Lee SA, Kwak MS, Kim S and Shin JS: The role of high mobility group box 1 in innate immunity. Yonsei Med J. 55:1165–1176. 2014. View Article : Google Scholar : PubMed/NCBI
24	Kouroumichakis I, Papanas N, Proikaki S, Zarogoulidis P and Maltezos E: Statins in prevention and treatment of severe sepsis and septic shock. Eur J Intern Med. 22:125–133. 2011. View Article : Google Scholar : PubMed/NCBI
25	Janda S, Young A, Fitzgerald JM, Etminan M and Swiston J: The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis. J Crit Care. 25:656.e7–22. 2010. View Article : Google Scholar
26	Beffa DC, Fischman AJ, Fagan SP, Hamrahi VF, Paul KW, Kaneki M, Yu YM, Tompkins RG and Carter EA: Simvastatin treatment improves survival in a murine model of burn sepsis: role of interleukin 6. Burns. 37:222–226. 2011. View Article : Google Scholar : PubMed/NCBI
27	Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D and Muñoz A: Unfractioned heparin for treatment of sepsis: a randomized clinical trial (The HETRASE Study). Crit Care Med. 37:1185–1196. 2009. View Article : Google Scholar : PubMed/NCBI
28	Zhao D, Ding R, Mao Y, Wang L, Zhang Z and Ma X: Heparin rescues sepsis-associated acute lung injury and lethality through the suppression of inflammatory responses. Inflammation. 35:1825–1832. 2012. View Article : Google Scholar : PubMed/NCBI
29	Spratte J, Meyer zu Schwabedissen H, Endlich N, Zygmunt M and Fluhr H: Heparin inhibits TNF-α signaling in human endometrial stromal cells by interaction with NF-κB. Mol Hum Reprod. 19:227–236. 2013. View Article : Google Scholar : PubMed/NCBI
30	Liu ZY, Zhu H and Ma XC: Systematic evaluation of heparin treatment in sepsis. Chin J Crit Care Med. 26:135–141. 2014.(In Chinese).
31	Wang P, Wang X, Zhang LJ, Yang F, Wang GX, Li XL and Huang X: Effect of low molecular weight heparin on the prognosis of elderly patients with severe pneumonia. Chin J Crit Care Med. 25:734–737. 2013.(In Chinese).
32	Gill SE, Taneja R, Rohan M, Wang L and Mehta S: Pulmonary microvascular albumin leak is associated with endothelial cell death in murine sepsis-induced lung injury in vivo. PLoS One. 9:e885012014. View Article : Google Scholar : PubMed/NCBI